Dexamethasone and cyclosporin A affect the maturation of monocyte-derived dendritic cells differently

International Archives of Allergy and Immunology

Volumn 122, Issue 1, 2000, Pages 76-84

  Manome, Hideaki ^a   Aiba, Setsuya ^a   Singh, Sanjay ^b   Yoshino, Yumiko ^a   Tagami, Hachiro ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antigen presentation; CD86; Cyclosporin A; Dendritic cells; Dexamethasone; Glucocorticoid

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; DEXAMETHASONE; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; STAPHYLOCOCCUS ENTEROTOXIN A; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034025134     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024361     Document Type: Article

References (36)

1. Wilckens T, De Rijk R: Glucocorticoids and immune function: Unknown dimensions and new frontiers. Immunol Today 1997;18:418-424.
2. Daynes RA, Araneo BA: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
3. Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT: Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J Immunol 1993;151:4081-4089.
4. Thomson AW: The effects of cyclosporin A on non-T cell components of the immune system. J Autoimmun 1992;5:167-176.
5. Moser M, De Smedt T, Sornasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J, Leo O: Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol 1995;25:2818-2824.
6. Holt PG, Thomas JA: Steroids inhibit uptake and/or processing but not presentation of antigen by airway dendritic cells. Immunology 1997;91:145-150.
7. Kitajima T, Ariizumi K, Bergstresser PR, Takashima A: A novel mechanism of glucocorticoid-induced immune suppression: The inhibition of T cell-mediated terminal maturation of a murine dendritic cell line. J Clin Invest 1996;98:142-147.
8. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, Jong EC: Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 1998;161:5245-5251.
9. Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone BE, Socci C, Di Carlo V: Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999;162:6473-6481.
10. Furue M, Katz SI: The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. J Immunol 1988;140:4139-4143.
11. Knight SC, Roberts M, Macatonia SE, Edwards AJ: Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Studies with fluorescent isothiocyanate. Transplantation 1988;46:48S-53S.
12. Roberts MS, Knight SC: Low-dose immunosuppression by cyclosporine operating via antigen-presenting dendritic cells. Transplantation 1990;50:91-95.
13. Dupuy P, Bagot M, Michel L, Descourt B, Dubertret L: Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol 1991;96:408-413.
14. Demidem A, Taylor JR, Grammer SF, Streilein JW: T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: Evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells. J Invest Dermatol 1991;97:454-460.
15. Teunissen MB, De Jager MH, Kapsenberg ML, Bos JD: Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells. Br J Dermatol 1991;125:309-316.
16. Granelli-Piperno A, Keane M, Steinman RM: Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation 1988;46:53S-60S.
17. Peguet-Navarro J, Slaats M, Thivolet J: Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function. Arch Dermatol Res 1991;283:198-202.
18. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252.
19. Aiba S, Tagami H: Dendritic cell activation induced by various stimuli, e.g. exposure to microorganisms, their products, cytokines, and simple chemicals as well as adhesion to extracellular matrix. J Dermatol Sci 1998;20:1-13.
20. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P: Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998;188:2175-2180.
21. Yokozeki H, Katayama I, Ohki O, Matsunaga T, Watanabe K, Satoh T, Azuma M, Okumura K, Nishioka K: Functional CD86 (B7-2/B80) on cultured human Langerhans cells. J Invest Dermatol 1996;106:147-153.
22. Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J: B70/ B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 1994;180:1841-1847.
23. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) exprcsssion on murine dendritic cells. J Immunol 1994;152:5208-5219.
24. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF6 is a signal transducer for interleukin-1. Nature 1996;383:443-446.
25. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor I signal transduction pathways. Cell 1996;84:299-308.
26. Lee HH, Dempsey PW, Parks TP, Zhu X, Baltimore D. Cheng G: Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. Proc Natl Acad Sci USA 1999;96:1421-1426.
27. Lee JI, Burckart GJ: Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 1998;38:981-993.
28. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.
29. Mourad W, Geha RS, Chatila T: Engagement of major histocompatibilily complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med 1990;172:1513-1516.
30. Trede NS, Geha RS, Chatila T: Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands. J Immunol 1991;146:2310-2315.
31. Mourad W, Mehindate K, Schall TJ, McColl SR: Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med 1992;175:613-616.
32. Garban F, Truman JP, Lord J, Drenou B, Plumas J, Jacob MC, Sotto JJ, Charron D, Mooney N: Signal transduction via human leukocyte antigen class II molecules distinguishes between cord blood, normal, and malignant adult B lymphocytes. Exp Hematol 1998;26:874-884.
33. Greer SF, Lin J, Clarke CH, Justement LB: Major histocompatibility class II-mediated signal transduction is regulated by the protein-tyrosine phosphatase CD45. J Biol Chem 1998;273:11970-11979.
34. Rich T, Lawler SE, Lord JM, Blancheteau VM, Charron DJ, Mooney NA: HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains. J Immunol 1997;159:3792-2798.
35. Truman JP, Choqueux C, Charron D, Mooney N: HLA class II molecule signal transduction leads to either apoptosis or activation via two different pathways. Cell Immunol 1996;172:149-157.
36. Truman JP, Garban F, Choqueux C, Charron D, Mooney N: HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 1996;24:1409-1415.